162 related articles for article (PubMed ID: 12527744)
21. In-vivo effects of Glu298Asp endothelial nitric oxide synthase polymorphism.
Sofowora G; Dishy V; Xie HG; Imamura H; Nishimi Y; Morales CR; Morrow JD; Kim RB; Stein CM; Wood AJ
Pharmacogenetics; 2001 Dec; 11(9):809-14. PubMed ID: 11740345
[TBL] [Abstract][Full Text] [Related]
22. Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population.
Candy G; Samani N; Norton G; Woodiwiss A; Radevski I; Wheatley A; Cockcroft J; Hall IP
J Hypertens; 2000 Feb; 18(2):167-72. PubMed ID: 10694184
[TBL] [Abstract][Full Text] [Related]
23. Lack of correlation between arterial and venous beta-adrenergic receptor sensitivity.
Stein CM; Deegan R; Wood AJ
Hypertension; 1997 Jun; 29(6):1273-7. PubMed ID: 9180628
[TBL] [Abstract][Full Text] [Related]
24. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27.
Lee DK; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jan; 57(1):100-4. PubMed ID: 14678347
[TBL] [Abstract][Full Text] [Related]
25. beta2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade.
Hesse C; Schroeder DR; Nicholson WT; Hart EC; Curry TB; Penheiter AR; Turner ST; Joyner MJ; Eisenach JH
J Physiol; 2010 Jul; 588(Pt 14):2669-78. PubMed ID: 20519311
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype.
Turki J; Pak J; Green SA; Martin RJ; Liggett SB
J Clin Invest; 1995 Apr; 95(4):1635-41. PubMed ID: 7706471
[TBL] [Abstract][Full Text] [Related]
27. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus.
Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD
Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937
[TBL] [Abstract][Full Text] [Related]
28. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function.
Summar ML; Gainer JV; Pretorius M; Malave H; Harris S; Hall LD; Weisberg A; Vaughan DE; Christman BW; Brown NJ
Hypertension; 2004 Feb; 43(2):186-91. PubMed ID: 14718356
[TBL] [Abstract][Full Text] [Related]
29. NG-monomethyl-L-arginine inhibits the blood flow but not the insulin-like response of forearm muscle to IGF- I: possible role of nitric oxide in muscle protein synthesis.
Fryburg DA
J Clin Invest; 1996 Mar; 97(5):1319-28. PubMed ID: 8636445
[TBL] [Abstract][Full Text] [Related]
30. Beta2-adrenoceptor genotype and function affect hemodynamic profile heterogeneity in postural tachycardia syndrome.
Jacob G; Garland EM; Costa F; Stein CM; Xie HG; Robertson RM; Biaggioni I; Robertson D
Hypertension; 2006 Mar; 47(3):421-7. PubMed ID: 16461848
[TBL] [Abstract][Full Text] [Related]
31. Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia.
Martin EA; Nicholson WT; Eisenach JH; Charkoudian N; Joyner MJ
J Appl Physiol (1985); 2006 Aug; 101(2):492-9. PubMed ID: 16614358
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
Whalen EJ; Bates JN; Johnson AK; Lewis SJ
Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
[TBL] [Abstract][Full Text] [Related]
33. Evidence for nitric oxide-mediated sympathetic forearm vasodiolatation in humans.
Dietz NM; Engelke KA; Samuel TT; Fix RT; Joyner MJ
J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):531-40. PubMed ID: 9032700
[TBL] [Abstract][Full Text] [Related]
34. The contribution of nitric oxide to exercise hyperemia in the human forearm.
Gordon MB; Jain R; Beckman JA; Creager MA
Vasc Med; 2002 Aug; 7(3):163-8. PubMed ID: 12553738
[TBL] [Abstract][Full Text] [Related]
35. Influence of beta2-adrenergic receptor genotype on airway function during exercise in healthy adults.
Snyder EM; Beck KC; Dietz NM; Joyner MJ; Turner ST; Johnson BD
Chest; 2006 Mar; 129(3):762-70. PubMed ID: 16537879
[TBL] [Abstract][Full Text] [Related]
36. Limb vascular responsiveness to beta-adrenergic receptor stimulation in patients with congestive heart failure.
Creager MA; Quigg RJ; Ren CJ; Roddy MA; Colucci WS
Circulation; 1991 Jun; 83(6):1873-9. PubMed ID: 1674899
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of beta-adrenergic receptor-mediated venodilation in humans.
Schindler C; Dobrev D; Grossmann M; Francke K; Pittrow D; Kirch W
Clin Pharmacol Ther; 2004 Jan; 75(1):49-59. PubMed ID: 14749691
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide synthase and cyclooxygenase modulate β-adrenergic cutaneous vasodilatation and sweating in young men.
Fujii N; McNeely BD; Kenny GP
J Physiol; 2017 Feb; 595(4):1173-1184. PubMed ID: 27779753
[TBL] [Abstract][Full Text] [Related]
39. Is nitric oxide involved in cutaneous vasodilation during body heating in humans?
Dietz NM; Rivera JM; Warner DO; Joyner MJ
J Appl Physiol (1985); 1994 May; 76(5):2047-53. PubMed ID: 7520431
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans.
Dietz NM; Rivera JM; Eggener SE; Fix RT; Warner DO; Joyner MJ
J Physiol; 1994 Oct; 480 ( Pt 2)(Pt 2):361-8. PubMed ID: 7869251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]